Myeloma and Related Diseases Registry (MRDR)

The annual Myeloma and Related Diseases Registry (MRDR) Interest Group breakfast is being held at Blood 2022. It will be a hybrid meeting, and live-streamed. Join us for an update on registry progress, projects, and registry-based discussion with the panel. Visit the news section of our website for registration details and the link for the meeting.

More information

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
5480

Patients accrued

3605

Patients with multiple myeloma

57

Number of approved sites

579

Biobank participants

Latest news

Myeloma and Related Diseases Registry (MRDR) Interest Group breakfast at Blood 2022.
24 Aug 2022

Join us for the Myeloma and Related Diseases Registry (MRDR) Interest Group breakfast at Blood 2022.

Read more
MRDR paper on early mortality in multiple myeloma accepted for publication
15 Jul 2022

Paper on on early mortality in multiple myeloma accepted for publication!

Read more
Rare Disease Day, Monday 28 Feb!
24 Feb 2022

Thanks to those who contribute to improving care, and providing support for people living with myeloma & related diseases!

Read more
MRFF grant for MY-PROMPT-2 trial!
11 Jan 2022

MY-PROMPT-2 project funded!

Read more

Participating organisations